Pop-Up Messages Up Physician Awareness of Osteoporosis

This article originally appeared here.
Share this content:
Pop-Up Messages Up Physician Awareness of Osteoporosis
Pop-Up Messages Up Physician Awareness of Osteoporosis

THURSDAY, May 12, 2016 (HealthDay News) -- The introduction of pop-up messages relating to a history of dual-energy X-Ray absorptiometry (DXA) in an order communication system can increase the rates of DXA prescription, as well as the rates of osteoporosis medication and exercise, according to a study published online May 6 in the Journal of Evaluation in Clinical Practice.

Joon Yub Kim, M.D., Ph.D., from Myongji Hospital in Goyang-si, South Korea, and colleagues compared the rate of DXA prescription, osteoporosis medication, exercise, mortality, and subsequent refractures for 404 patients treated without and with pop-up messages, implemented in March 2012. Patients were followed for a two-year period.

The researchers found that the DXA prescription rate increased from 35.1 to 57.1 percent after introducing the pop-up messages (P < 0.001). Furthermore, there was an increase in the osteoporosis medication rate from 21.1 to 25.2 percent, and in the exercise rate from 35.6 to 40.5 percent (P = 0.05 and 0.018, respectively). The mortality rates were 4.64 in the group treated before implementation of pop-up messages and 6.67 percent for those treated after implementation (P = 0.4). Subsequent refractures occurred in 12.9 and 9.52 percent of those treated before and after implementation of pop-up messages, respectively (P = 0.87).

"We recommend using this simple and effective method to improve physicians' awareness of osteoporosis," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »